EW
NYSEEdwards Lifesciences Corp
Health Care, Health Care Equipment
$89.72
close 7 Aug 2026
+14.79%
52-week change
$51.73B
market cap
$72.30
$96.29
52-week range
Valuation
Market cap$51.73B
P/E (TTM / 5y avg)51.56x33.11x
Forward P/E (FY2026 / FY2027)29.92x26.58x
PEG (TTM / fwd)—2.38
P/S (TTM)7.94x
P/B4.87x
EV/EBITDA (TTM)30.61x
FCF yield (TTM)2.77%
Cash flow & dividend
FCF (TTM)$1.43B
FCF per share (TTM)$2.49
FCF margin (TTM)22.01%
Dividend yield (indicated / 5y avg)——
Annualized dividend—
Payout ratio (EPS / FCF)——
Growth & quality
Revenue YoY, latest Q+13.63%
Diluted EPS YoY, latest Q-25.00%
Operating margin (TTM)22.25%
Net margin (TTM)15.46%
ROE (latest FY)10.38%
Net debt / EBITDA (TTM)-1.43
Interest coverage (TTM)71.03
Price
-20.71%-4.55%/yrover 5y
Weekly closes · split-adjusted
close 7 Aug 2026
Fundamentals
Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar
Revenue
5Y CAGR +6.70%10Y CAGR +9.30%
Diluted EPS
5Y CAGR +7.08%10Y CAGR +9.33%
FCF per share
5Y CAGR +17.36%10Y CAGR +12.88%
Operating cash flow
5Y CAGR +8.64%10Y CAGR +11.24%
Free cash flow
5Y CAGR +15.58%10Y CAGR +11.56%
Operating margin
FCF margin
Return on equity
Return on capital employed
Shares outstanding
5Y CAGR -1.44%10Y CAGR -1.06%
Net debt / EBITDA
Interest coverage
Earnings
Street estimates, not SEC filings
Next / Q3 FY26
Date28 Oct 2026amc
EPS estimate$0.7597
Revenue estimate$1.73B
Last reported
Date—
EPS——
Revenue——